My Treatment Approach: Optimizing Care for Relapsed / Refractory Multiple Myeloma: Translating Evidence to Clinical Practice : Episode 2

Opinion

Video

August 14, 2024

Clinical Insights on Next Treatment Approach Steps

Author(s):

Robert Z. Orlowski, MD, PhD,Jonathan L. Kaufman, MD

A panel of experts in relapsed/refractory multiple myeloma analyzes a patient case, detailing their clinical approach to optimize outcomes for a 68-year-old male presenting with early relapse multiple myeloma.

EP: 1.Clinical Scenario I: 68-yr Old Man with Early Relapse MM

Now Viewing

EP: 2.Clinical Insights on Next Treatment Approach Steps

EP: 3.Real Life Clinical Practice Use of Selinexor: Dosing Strategies, Supportive Care, and Strategies to Incorporate into Novel Selinexor-Based Regimens

EP: 4.Expert Perspectives: Navigating the Evolving Treatment Landscape in Early Relapse MM

EP: 5.Overview of CAR T-cell Therapy Options in R/R MM

EP: 6.Expert Perspectives: Selinexor Role in the Changing Treatment Landscape in MM and Key Takeaways

EP: 7.Patient Profile: 53-Year-Old Man with Heavily Pre-Treated MM including T-cell Directed Therapy

EP: 8.Clinical Insights on the Patient Presentation & Treatment Course

EP: 9.Challenges of Treatment Sequencing in Heavily Pre-Treated R/R MM: Expert Insights

EP: 10.Potential Novel Lab Monitoring & Key Takeaways for Heavily Pre-Treated R/R MM

EP: 11.Clinical Pearls & Unmet Needs in Early and Late Relapse R/R MM

Video content above is prompted by the following:

Please describe your initial impressions of this case. How might you have treated this patient in your practice?

Latest Conference Coverage

Zongertinib Elicits Durable Responses in Pretreated Advanced HER2-Mutant NSCLC

Lenvatinib Shows Efficacy in Advanced HCC Post-Progression on Atezolizumab/Bevacizumab

Sacituzumab Govitecan Does Not Significantly Improve OS in Pretreated Urothelial Carcinoma

Active Monitoring Is Noninferior to Guideline Concordant Care in Low-Risk DCIS

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512